Dr Andrew Mallett
Dr

Andrew Mallett

Email: 

Background

Professor Andrew Mallett is a Nephrologist with a special interest in inherited kidney disease and nephrogenetics. After graduating from James Cook University (MBBS, 2006) he completed physician training at Mackay Base Hospital, Royal Brisbane and Women's Hospital and Princess Alexandra Hospital (MMed USyd, 2009; AFRACMA 2011; FRACP 2013; FASN 2016). Professor Mallett has undertaken a Churchill Fellowship and been a recurrent Visiting Fellow at Addenbrooke's Hospital (Cambridge, UK) and the Cambridge Institute for Medical Research (University of Cambridge). He has completed a PhD in nephrogenetics collaborating nationally and internationally, and is a Consultant Nephrologist at RBWH, co-leading the statewide Queensland Conjoint Renal Genetics Service. Professor Mallett is National Director of KidGen, the AGHA Renal Genetics Rare Disease Flagship.

Availability

Dr Andrew Mallett is:
Available for supervision
Media expert

Search Professor Andrew Mallett’s works on UQ eSpace

233 works between 2012 and 2025
All (233) Journal Article (176) Other Outputs (1) Conference Publication (55) Book Chapter (1)

61 - 80 of 233 works

2024

Journal Article

Update Thiazide Diuretic evidence review for CARI guidelines kidney stones recommendations

Tunnicliffe, David J., Mallett, Andrew, Cashmore, Brydee, Mullan, Adam, Lloyd, Lyn, Yip, Adela, Wickham, Ieuan, Hassan, Hicham and Jose, Matthew (2024). Update Thiazide Diuretic evidence review for CARI guidelines kidney stones recommendations. Kidney International Reports, 9 (5), 1145-1148. doi: 10.1016/j.ekir.2024.02.1398

Update Thiazide Diuretic evidence review for CARI guidelines kidney stones recommendations

2024

Journal Article

Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead

Mallett, Andrew J., Ingles, Jodie, Goranitis, Ilias and Stark, Zornitza (2024). Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead. Internal Medicine Journal, 54 (4), 531-534. doi: 10.1111/imj.16369

Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead

2024

Journal Article

Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995-2014

Ng, Monica Suet Ying, Jones, Andrew Thomas, Mallett, Andrew John and Marie O'Shaughnessy, Michelle (2024). Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995-2014. Nephrology Dialysis Transplantation, 39 (11), 1846-1855. doi: 10.1093/ndt/gfae081

Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995-2014

2024

Conference Publication

WCN24-1130 Association Of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Cardiovascular Disease And Mortality In Patients With Treated Kidney Failure

Jefferis, Julia, Mallett, Andrew, Rangan, Gopi, Cho, Yeoungjee, Viecelli, Andrea, Vangaveti, Venkat, Johnson, David and Hawley, Carmel (2024). WCN24-1130 Association Of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Cardiovascular Disease And Mortality In Patients With Treated Kidney Failure. ISN World Congress of Nephrology (WCN) 2024, Buenos Aires, Argentina, 13-16 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.ekir.2024.02.655

WCN24-1130 Association Of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Cardiovascular Disease And Mortality In Patients With Treated Kidney Failure

2024

Conference Publication

Molecular diagnostic yield for COL4A3/4/5 across clinical phenotypes suggestive of Alport Syndrome in 2 health systembased cohorts and a clinical cohort

Chang, Alexander, Retterer, Kyle, Murphy, Karyn, Wongboonsin, Janewit, Kelly, Melissa, Biros, Erik, Mallett, Andrew and Sampson, Matthew (2024). Molecular diagnostic yield for COL4A3/4/5 across clinical phenotypes suggestive of Alport Syndrome in 2 health systembased cohorts and a clinical cohort. ISN World Congress of Nephrology (WCN) 2024, Buenos Aires, Argentina, 13-16 April 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.ekir.2024.02.705

Molecular diagnostic yield for COL4A3/4/5 across clinical phenotypes suggestive of Alport Syndrome in 2 health systembased cohorts and a clinical cohort

2024

Journal Article

People with genetic kidney diseases on kidney replacement therapy have different clinical outcomes compared to people with other kidney diseases

Han, Helen Y., Vangaveti, Venkat, Jose, Matthew, Ng, Monica Suet Ying and Mallett, Andrew John (2024). People with genetic kidney diseases on kidney replacement therapy have different clinical outcomes compared to people with other kidney diseases. Scientific Reports, 14 (1) 6746, 1-10. doi: 10.1038/s41598-024-57273-x

People with genetic kidney diseases on kidney replacement therapy have different clinical outcomes compared to people with other kidney diseases

2024

Journal Article

A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials

Stanley, I. Kitty, Palma, Anton M., Viecelli, Andrea K., Johnson, David W., Hawley, Carmel M., Staatz, Christine E. and Mallett, Andrew J. (2024). A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials. Journal of Nephrology, 37 (5), 1417-1419. doi: 10.1007/s40620-024-01906-x

A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials

2024

Journal Article

Characteristics and clinical outcomes of patients with kidney failure of unknown aetiology from ANZDATA registry

Wang, Lucy S., Vangaveti, Venkat, Ng, Monica S. Y. and Mallett, Andrew J. (2024). Characteristics and clinical outcomes of patients with kidney failure of unknown aetiology from ANZDATA registry. PLoS One, 19 (3) e0300259, 1-11. doi: 10.1371/journal.pone.0300259

Characteristics and clinical outcomes of patients with kidney failure of unknown aetiology from ANZDATA registry

2024

Journal Article

Describing and explaining ADPKD variability within families

Achi, Sai Santhoshini and Mallett, Andrew J. (2024). Describing and explaining ADPKD variability within families. Kidney International Reports, 9 (3), 523-525. doi: 10.1016/j.ekir.2024.01.046

Describing and explaining ADPKD variability within families

2024

Journal Article

Exploring the impact and utility of genomic sequencing in established CKD

Jefferis, Julia and Mallett, Andrew J (2024). Exploring the impact and utility of genomic sequencing in established CKD. Clinical Kidney Journal, 17 (3) sfae043, sfae043. doi: 10.1093/ckj/sfae043

Exploring the impact and utility of genomic sequencing in established CKD

2024

Journal Article

A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline

Stanley, Kitty, Mallett, Andrew J., Viecelli, Andrea K., Hawley, Carmel M., Staatz, Christine E., Johnson, David W. and Milanzi, Elasma (2024). A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline. Kidney International Reports, 9 (5), 1525-1527. doi: 10.1016/j.ekir.2024.02.011

A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline

2024

Journal Article

Beyond DNA sequencing: genetic kidney disorders related to altered splicing

McCarthy, Hugh J, Mallett, Andrew J, Sullivan, Patricia, Cowley, Mark J and Mallawaarachchi, Amali C (2024). Beyond DNA sequencing: genetic kidney disorders related to altered splicing. Nephrology Dialysis Transplantation, 39 (7), 1056-1059. doi: 10.1093/ndt/gfae022

Beyond DNA sequencing: genetic kidney disorders related to altered splicing

2024

Journal Article

Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review

Robinson, Michael, Mokrzecki, Sophie and Mallett, Andrew J. (2024). Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review. npj Aging, 10 (1) 6, 1-6. doi: 10.1038/s41514-023-00132-2

Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review

2024

Journal Article

Response to Correspondence on “Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation” (Lombardi and Mesnard, 2023)

Wu, You, Jayasinghe, Kushani, Stark, Zornitza, Quinlan, Catherine, Patel, Chirag, McCarthy, Hugh, Mallawaarachchi, Amali C., Kerr, Peter G., Alexander, Stephen I., Mallett, Andrew J. and Goranitis, Ilias (2024). Response to Correspondence on “Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation” (Lombardi and Mesnard, 2023). Genetics in Medicine, 26 (1) 100989, 100989. doi: 10.1016/j.gim.2023.100989

Response to Correspondence on “Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation” (Lombardi and Mesnard, 2023)

2023

Journal Article

Polypharmacy in older patients presenting to a tertiary regional health service: identifying correlations between demographics, presentations and length of stay

Robinson, Michael, Vangaveti, Venkat, Mokrzecki, Sophie and Mallett, Andrew J. (2023). Polypharmacy in older patients presenting to a tertiary regional health service: identifying correlations between demographics, presentations and length of stay. Internal Medicine Journal, 53 (12), 2336-2340. doi: 10.1111/imj.16291

Polypharmacy in older patients presenting to a tertiary regional health service: identifying correlations between demographics, presentations and length of stay

2023

Journal Article

Determining the utility of diagnostic genomics: a conceptual framework

Mallett, Andrew, Stark, Zornitza, Fehlberg, Zoe, Best, Stephanie and Goranitis, Ilias (2023). Determining the utility of diagnostic genomics: a conceptual framework. Human Genomics, 17 (1) 75, 75. doi: 10.1186/s40246-023-00524-1

Determining the utility of diagnostic genomics: a conceptual framework

2023

Journal Article

Monogenic and polygenic concepts in chronic kidney disease (CKD)

Jefferis, Julia, Hudson, Rebecca, Lacaze, Paul, Bakshi, Andrew, Hawley, Carmel, Patel, Chirag and Mallett, Andrew (2023). Monogenic and polygenic concepts in chronic kidney disease (CKD). Journal of Nephrology, 37 (1), 7-21. doi: 10.1007/s40620-023-01804-8

Monogenic and polygenic concepts in chronic kidney disease (CKD)

2023

Journal Article

Association of primary kidney disease type and donor relatedness with live donor kidney transplant outcomes: an analysis of ANZDATA

Yu, Dong, Malacova, Eva, Hurst, Cameron, Ng, Monica Suet Ying and Mallett, Andrew John (2023). Association of primary kidney disease type and donor relatedness with live donor kidney transplant outcomes: an analysis of ANZDATA. American Journal of Kidney Diseases, 82 (5), 569-580.e1. doi: 10.1053/j.ajkd.2023.04.004

Association of primary kidney disease type and donor relatedness with live donor kidney transplant outcomes: an analysis of ANZDATA

2023

Conference Publication

Patient Mortality and Graft Failure Risks in Transplant Recipients with Kidney Failure Secondary to Genetic Kidney Disease Compared to People with Other Kidney Diseases

Ng, Monica S., Han, Helen, Vangaveti, Venkat, Jose, Matthew D. and Mallett, Andrew J. (2023). Patient Mortality and Graft Failure Risks in Transplant Recipients with Kidney Failure Secondary to Genetic Kidney Disease Compared to People with Other Kidney Diseases. Kidney Week, Philadelphia, PA United States, 1-5 November 2023. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1681/asn.20233411s1576d

Patient Mortality and Graft Failure Risks in Transplant Recipients with Kidney Failure Secondary to Genetic Kidney Disease Compared to People with Other Kidney Diseases

2023

Journal Article

Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation

Wu, You, Jayasinghe, Kushani, Stark, Zornitza, Quinlan, Catherine, Patel, Chirag, McCarthy, Hugh, Mallawaarachchi, Amali C., Kerr, Peter G., Alexander, Stephen, Mallett, Andrew J., Goranitis, Ilias and on behalf of The KidGen Collaborative investigators (2023). Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation. Genetics in Medicine, 25 (11) 100942, 100942. doi: 10.1016/j.gim.2023.100942

Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation

Current funding

  • 2025 - 2026
    KidGen Collaborative: Effective, efficient and equitable care of patients with genetic kidney disease through a national network of multidisciplinary clinics and education programs
    Commonwealth Department of Health
    Open grant
  • 2023 - 2028
    IMPEDE-PKD: Metformin to protect kidney function in polycystic kidney disease
    University of Otago
    Open grant
  • 2022 - 2025
    Genomic Approaches to Kidney Health and Disease
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2020 - 2027
    Implementation of Metformin theraPy to Ease DEcline of kidney function in PKD - the IMPEDE-PKD trial
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2021 - 2022
    Rab GTPase regulation in Ciliogenesis and Polycystic Kidney Disease
    PKD Foundation of Australia Limited
    Open grant
  • 2020 - 2023
    KidGen Clinics, Education, Data and Research (KidGen CEDAR): Improving Care and Outcomes of Australians with Genetic Kidney Disease
    Commonwealth Department of Health
    Open grant
  • 2020 - 2021
    Applying Spatial Transcriptomics to Discover Kidney Disease Pathways and Optimize Clinical Kidney Biopsy Assessment
    Metro North Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018
    The HIDDEN Study (wHole genome Investigation to iDentify unDEtected Nephropathies) - Applying Genomics to Understand Unexplained End Stage Kidney Disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2016 - 2019
    Applying functional genomics to kidney disease (NHMRC Project Grant Administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant

Availability

Dr Andrew Mallett is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Dr Andrew Mallett directly for media enquiries about:

  • Alport Syndrome
  • clinical genomic
  • genetic kidney disease
  • genetics
  • genomics
  • inherited kidney disease
  • kidney
  • kidney disease
  • kidney genetics
  • nephrology
  • polycystic kidney disease
  • renal genetics

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au